Despite the negative outcome of recent trials there is growing evidence that there are
increasing opportunities in patients with lupus nephritis to offer treatments tailored to the …

In the past years, many (randomized) trials have been performed comparing the treatment
strategies for lupus nephritis. In 2012, these data were incorporated in six different …

The optimal treatment of severe lupus nephritis remains unclear. Regimens consisting of
steroid and cyclophosphamide (CYC) appear to be most effective. Infection and gonadal …

Lupus nephritis is an important manifestation of systemic lupus erythematosus, which leads
to chronic kidney disease, kidney failure, and can result in mortality. About 35%–60% of …

The collaborative efforts of patients, clinical and translational researchers, the
pharmaceutical industry and funding sources are needed to advance therapies for lupus …

Abstract Lupus nephritis affects 50-75% of all children with systemic lupus erythematosus
with a higher prevalence in Asians. Itremains a major contributor to morbidity and mortality in …

Update on the treatment of lupus nephritis : Current Opinion in Nephrology and Hypertension
Update on the treatment of lupus nephritis : Current Opinion in Nephrology and Hypertension …

The treatment of lupus nephritis has changed significantly over the past decade in large part
because of data from well-conducted randomized clinical trials. The concept of two phases …

Abstract Purpose of Review Update on the diagnosis, treatment, and monitoring of lupus
nephritis. Recent Findings The recent criteria enable the earlier classification of lupus …

Kidney involvement in systemic lupus erythematosus (SLE), generally termed lupus
nephritis, is a major contributor to SLE-associated morbidity and mortality. Up to 50% of SLE …